Spruce Biosciences (SPRB) Stock jumps 30% after hours after the Red Hot Rally on Monday: here is why

Spruce Biosciences Inc. (Nasdaq: SPRB) jumped to $ 175.00 during the trade after the hours on Monday, an increase of 34.20% or $ 44.60 compared to the final race.

View the current price of SPRB shares here.

During regular trading hours, SPRB increased $ 121.58, which marked a profit of 1,378.46% and according to Benzinga Pro data $ 130.40 closes.

FDA grants breakthrough indication

On October 6, Spruce Biosciences announced that the Food and Drug Administration (FDA) thanks to the breakthrough therapy indication to the enzyme replacement therapy, trilesinidase alfa, for the treatment of the Sanfilippo syndrome type B (MPS IIIB).

Spruce Biosciences Market Data

In the second quarter, SPRB reported a loss of $ 3.50 per share, whereby the analyst expectations of a loss of $ 20.25 were defeated by 82.7%. It reported no income for the quarter and did not fall at the estimated $ 200,000.

The next winning report is planned for November 10.

Spruce Biosciences has delivered exceptional stock performance, with 1,996.46% climbing in the past six months and achieved 1,348.89% in the past month.

In the past year, shares have traded a range from $ 5.85 to $ 170.00. The company has a market capitalization of $ 73.42 million and an average daily trade volume of 11,170 shares.

Benzinga Edge Stock Rankings indicate That SPRB has a negative price trend for all time frames. Follow the performance of other players in this segment.

Read next:

Photo Courtesy: Tom Robertson on Shutterstock.com:

Safeguard: This content was partially produced with the help of AI tools and was assessed and published by Benzinga Editors.